The journal of vascular access · 2017
Peripherally inserted central catheter-related complications in cancer patients: a prospective study of over 50,000 catheter days.
СтатьяМногоцентровое исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kang Junren, Chen Wei, Sun Wenyan, Ge Ruibin, Li Hailong, Ma Enling, Su Qingxia, Cheng Fang, Hong Jinhua, Zhang Yuanjuan, Lei Cheng, Wang Xinchuan, Jin Aiyun, Liu Wanli
Аннотация
PURPOSE: To evaluate incidence and risk factors of peripherally inserted central catheter (PICC)-related complications in cancer patients.
METHODS: A prospective, multicenter, cohort study of cancer patients with PICC insertion was performed from February 1, 2013 to April 24, 2014. All patients were monitored in clinic until PICCs were removed. The primary endpoint was PICC removal due to complications. Patient-, catheter- and insertion-related factors were analyzed in univariable and multivariable logistic regression analysis to identify significant independent risk factors for PICC-related complications.
RESULTS: There were 477 cancer patients included, for a total of 50,841 catheter-days. Eighty-one patients (17.0%) developed PICC-related complications, with an incidence of 1.59 per 1000 catheter days. Thirty-six (7.5%) PICCs were removed because of complications. The most common complications were skin allergy (4.6%), catheter occlusion (3.4%) and accidental withdrawal (2.3%). Nine (1.9%) patients developed symptomatic upper extremity deep venous thrombosis (UEDVT) and central line associated bloodstream infection (CLABSI) was shown in six (1.3%) PICCs with an infection rate 0.12 per 1000 catheter days. In multivariable analysis, body mass index (BMI) >25 (odds ratio, 2.09; 95% confidence interval, 1.26-3.47, p = 0.004) was shown to be a significant risk factor for PICC complications.
CONCLUSIONS: Cancer patients with BMI greater than 25 were more likely to have PICC complications.
METHODS: A prospective, multicenter, cohort study of cancer patients with PICC insertion was performed from February 1, 2013 to April 24, 2014. All patients were monitored in clinic until PICCs were removed. The primary endpoint was PICC removal due to complications. Patient-, catheter- and insertion-related factors were analyzed in univariable and multivariable logistic regression analysis to identify significant independent risk factors for PICC-related complications.
RESULTS: There were 477 cancer patients included, for a total of 50,841 catheter-days. Eighty-one patients (17.0%) developed PICC-related complications, with an incidence of 1.59 per 1000 catheter days. Thirty-six (7.5%) PICCs were removed because of complications. The most common complications were skin allergy (4.6%), catheter occlusion (3.4%) and accidental withdrawal (2.3%). Nine (1.9%) patients developed symptomatic upper extremity deep venous thrombosis (UEDVT) and central line associated bloodstream infection (CLABSI) was shown in six (1.3%) PICCs with an infection rate 0.12 per 1000 catheter days. In multivariable analysis, body mass index (BMI) >25 (odds ratio, 2.09; 95% confidence interval, 1.26-3.47, p = 0.004) was shown to be a significant risk factor for PICC complications.
CONCLUSIONS: Cancer patients with BMI greater than 25 were more likely to have PICC complications.
Предметные рубрики MeSH
Administration, IntravenousAdolescentAdultAgedAged, 80 and overAntineoplastic AgentsCatheter ObstructionCatheter-Related InfectionsCatheterization, Central VenousCatheterization, PeripheralCatheters, IndwellingCentral Venous CathetersChinaDermatitis, Allergic ContactFemaleHumansIncidenceLogistic ModelsMaleMiddle AgedMultivariate AnalysisNeoplasmsOdds RatioProspective StudiesRisk AssessmentRisk FactorsTime FactorsTreatment OutcomeUpper Extremity Deep Vein ThrombosisYoung Adult